Myofibrillogenesis regulator 1 gene (MR-1) mutation in an Omani family with paroxysmal nonkinesigenic dyskinesia

A Hempelmann, S Kumar, S Muralitharan, T Sander - Neuroscience letters, 2006 - Elsevier
A Hempelmann, S Kumar, S Muralitharan, T Sander
Neuroscience letters, 2006Elsevier
Two recurrent missense mutations (c. 20C> T: A7V; c. 26C> T: A9V) in the gene encoding
the myofibrillogenesis regulator 1 (MR-1) have been shown to cause autosomal dominant
paroxysmal nonkinesigenic dyskinesia (PNKD) in 13 families of primarily European
ancestry. Here we report an Omani PNKD family with seven affected family members and
autosomal dominant inheritance. Our linkage analysis provided consistent positional
evidence that the MR-1 gene could be the responsible disease gene. Sequence analysis …
Two recurrent missense mutations (c.20C>T: A7V; c.26C>T: A9V) in the gene encoding the myofibrillogenesis regulator 1 (MR-1) have been shown to cause autosomal dominant paroxysmal nonkinesigenic dyskinesia (PNKD) in 13 families of primarily European ancestry. Here we report an Omani PNKD family with seven affected family members and autosomal dominant inheritance. Our linkage analysis provided consistent positional evidence that the MR-1 gene could be the responsible disease gene. Sequence analysis identified a MR-1 missense mutation (c.20C>T; A7V) in the affected family members, whereas it was not present in five unaffected family members and 129 population controls. Taking into account that previous haplotype analyses did not reveal evidence for common founders among several PNKD families, our present findings strengthen three implications: (1) autosomal dominant PNKD seems to be a homogenous disorder, for which the MR-1 gene is the major disease gene; (2) mainly two recurrent MR-1 missense mutations (57% V7, 43% V9) account for the genetic variance of familial PNKD; (3) it supports current evidence that some of the recurrent MR-1 mutations may have arisen independently by de novo mutation at functionally convergent key sites of the brain-specific MR-1L isoform.
Elsevier